Cocrystal Pharma Price To Sales vs. Total Debt
| COCP Stock | USD 1.91 0.05 2.69% |
Cocrystal Pharma Price To Sales Ratio |
|
For Cocrystal Pharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Cocrystal Pharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Cocrystal Pharma utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Cocrystal Pharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Cocrystal Pharma over time as well as its relative position and ranking within its peers.
Cocrystal |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cocrystal Pharma. If investors know Cocrystal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cocrystal Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.84) | Revenue Per Share 0.006 | Quarterly Revenue Growth 0.269 | Return On Assets (0.46) | Return On Equity (0.69) |
The market value of Cocrystal Pharma is measured differently than its book value, which is the value of Cocrystal that is recorded on the company's balance sheet. Investors also form their own opinion of Cocrystal Pharma's value that differs from its market value or its book value, called intrinsic value, which is Cocrystal Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cocrystal Pharma's market value can be influenced by many factors that don't directly affect Cocrystal Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cocrystal Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cocrystal Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cocrystal Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cocrystal Pharma Total Debt vs. Price To Sales Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Cocrystal Pharma's current stock value. Our valuation model uses many indicators to compare Cocrystal Pharma value to that of its competitors to determine the firm's financial worth. Cocrystal Pharma is rated third in price to sales category among its peers. It is rated below average in total debt category among its peers making up about 20,042 of Total Debt per Price To Sales. At this time, Cocrystal Pharma's Price To Sales Ratio is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Cocrystal Pharma by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Cocrystal Total Debt vs. Price To Sales
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Cocrystal Pharma |
| = | 92.45 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Cocrystal Pharma |
| = | 1.85 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Cocrystal Total Debt vs Competition
Cocrystal Pharma is rated below average in total debt category among its peers. Total debt of Health Care industry is currently estimated at about 70.18 Million. Cocrystal Pharma holds roughly 1.85 Million in total debt claiming about 2.64% of equities under Health Care industry.
Cocrystal Pharma Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Cocrystal Pharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Cocrystal Pharma will eventually generate negative long term returns. The profitability progress is the general direction of Cocrystal Pharma's change in net profit over the period of time. It can combine multiple indicators of Cocrystal Pharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -18.6 M | -19.5 M | |
| Income Before Tax | -18 M | -18.9 M | |
| Total Other Income Expense Net | 575 K | 603.8 K | |
| Net Loss | -18 M | -18.9 M | |
| Income Tax Expense | (1.00) | (1.05) | |
| Net Loss | -18 M | -18.9 M | |
| Non Operating Income Net Other | -62.1 K | -65.2 K | |
| Net Loss | -35 M | -36.7 M | |
| Interest Income | 213.3 K | 202.6 K | |
| Net Interest Income | 460 K | 483 K | |
| Change To Netincome | 22.7 M | 23.7 M | |
| Net Loss | (1.86) | (1.96) | |
| Income Quality | 0.82 | 0.77 | |
| Net Income Per E B T | 1.15 | 0.97 |
Cocrystal Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Cocrystal Pharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Cocrystal Pharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Cocrystal Pharma's important profitability drivers and their relationship over time.
Use Cocrystal Pharma in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cocrystal Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cocrystal Pharma will appreciate offsetting losses from the drop in the long position's value.Cocrystal Pharma Pair Trading
Cocrystal Pharma Pair Trading Analysis
The ability to find closely correlated positions to Cocrystal Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cocrystal Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cocrystal Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cocrystal Pharma to buy it.
The correlation of Cocrystal Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cocrystal Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cocrystal Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cocrystal Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Cocrystal Pharma position
In addition to having Cocrystal Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Recycling Thematic Idea Now
Recycling
West management companies as well as entities specializing in pollution control and recycling. The Recycling theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Recycling Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Cocrystal Stock Analysis
When running Cocrystal Pharma's price analysis, check to measure Cocrystal Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cocrystal Pharma is operating at the current time. Most of Cocrystal Pharma's value examination focuses on studying past and present price action to predict the probability of Cocrystal Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cocrystal Pharma's price. Additionally, you may evaluate how the addition of Cocrystal Pharma to your portfolios can decrease your overall portfolio volatility.